Attached files
| file | filename |
|---|---|
| EX-10.7 - NON-EMPLOYEE DIRECTOR COMPENSATION POLICY - ENDRA Life Sciences Inc. | end_ex107.htm |
| S-1/A - AMENDMENT NO. 5 - ENDRA Life Sciences Inc. | end_s1a5.htm |
Exhibit 23.1
CONSENT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING
FIRM
We hereby consent
to the reference to our firm under the caption
“Experts” and the use of our report dated July 15,
2016, except for the effect of the restatements discussed in Note 3
to the financial statements, for which the date is January 19, 2017
and except for Note 11, as to which the date is December 16, 2016,
which includes an explanatory paragraph regarding the substantial
doubt about the Company’s ability to continue as a going
concern, on the financial statements of ENDRA Life Sciences Inc.
which appears in this Registration Statement on Form S-1 Amendment
No. 5.
/s/ RBSM
LLP
Henderson,
NV
January 20,
2017